The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
The DOI matches its Crossref record; 791 of the 808 references it cites were found in a registry or an index.
Abstract
The inflammatory response is a highly regulated physiological process that is critically important for homeostasis. A precise physiological control of inflammation allows a timely reaction to invading pathogens or to other insults without causing overreaction liable to damage the host. The cellular signaling pathways identified as important regulators of inflammation are the signal transduction cascades mediated by the nuclear factor-kappaB and the activator protein-1, which can both be modulated by glucocorticoids. Their use in the clinic includes treatment of rheumatoid arthritis, asthma, allograft rejection, and allergic skin diseases. Although glucocorticoids have been widely used since the late 1940s, the molecular mechanisms responsible for their antiinflammatory activity are still under investigation. The various molecular pathways proposed so far are discussed in more detail.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It acts through the glucocorticoid receptor (GR), which modulates gene expression by suppressing pro-inflammatory signaling pathways involving transcription factors such as NF-κB and AP-1 [18].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [18]
In the citing paper
“GCs also decrease immune activation via protein-protein interactions between GR and NF-κB in the nucleus (Figure 1) (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“Moreover, chronic exposure to GCs (particularly synthetic GCs at supra-physiological levels) inhibits both innate and adaptive immunity.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“For example, chronic GC exposure reduces circulating leukocyte counts and decreases the production of a large variety of proinflammatory cytokines including IL-1β and TNF-α (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
Citations
Cites
2 retracted
Watanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K.-I., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1341 · Cited by 267
RetractedAdcock, I. M., Nasuhara, Y., Stevens, D. A., & Barnes, P. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702613 · Cited by 119
RetractedJenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 3×
“By analogy with histone code (465, 469, 470, 517), the interplay of modifications at the cofactor (370, 371) and transcription factor levels (418, 518–521) may similarly have important functional implications (such as, e.”
BackgroundThe language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 1×
“Besides acetylation, other posttranslational modifications such as phosphorylation and methylation also do occur in core histone tails (465, 466, 469, 470, 475).”
BackgroundNF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034 · cited 1×
“Many proinflammatory cytokines, aberrantly up-regulated in chronic inflammatory diseases, require the concerted activation of NF- B and AP-1, which are positively controlled by MAPK cascades (708, 709).”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Research works printed but not linked: 11
- Delerive, 2002, DNA-binding independent regulation of IκB-α gene transcription by PPARα., Mol Endocrinol, 16, 1029
- Benecke, 1998, Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap., Gene Ther Mol Biol, 3, 1
- Herrlich, 2001, Cross-talk between glucocorticoid receptor and AP-1., Oncogene, 20, 2465, 10.1038/sj.onc.1204388 · DOI · Paper page
- Lidén, 2000, Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene., Biochem Biophys Res Commun, 273, 1008, 10.1006/bbrc.2000.3079 · DOI
- Chen, 1999, Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells., J Cell Biochem, 74, 418, 10.1002/(sici)1097-4644(19990901)74:3<418::aid-jcb10>3.0.co;2-6 · DOI · Paper page
- Chen, 1999, Association of the glucocorticoid receptor alternatively-spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells., J Cell Biochem, 74, 430, 10.1002/(sici)1097-4644(19990901)74:3<430::aid-jcb11>3.0.co;2-5 · DOI · Paper page
- Webster, 2001, Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance., Proc Natl Acad Sci USA, 98, 6865, 10.1073/pnas.121455098 · DOI · Paper page
- De Vera, 1997, Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB, Am J Physiol, 273, G1290
- Han, 1999, Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide., Eur J Immunol, 29, 1334, 10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0 · doi:10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0
- Sengupta, 2000, Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells., EMBO J, 19, 6051, 10.1093/emboj/19.22.6051 · DOI
- Lee, 1998, Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter., EMBO J, 17, 1454, 10.1093/emboj/17.5.1454 · DOI
Cited by
Items 201–300 of 918
Glucocorticoids inhibitGATA‐3 phosphorylation and activity in T cells
Liberman, A. C., Druker, J., Refojo, D., Holsboer, F., & Arzt, E. (2009) · The FASEB Journal · doi:10.1096/fj.08-121236 · Cited by 87
Sarno, E., Moeser, A. J., & Robison, A. J. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.004 · Cited by 91
Shah, S., King, E. M., Chandrasekhar, A., & Newton, R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540799 · Cited by 89
“One explanation for these repressive effects is interaction of NR3C1 with inflammatory transcription factors, such as nuclear factor (NF)- B or activator protein-1 (7).”
BackgroundEnvironmental Stressors and Epigenetic Control of the Hypothalamic-Pituitary-Adrenal Axis
Lee, R. S., & Sawa, A. (2014) · Neuroendocrinology · doi:10.1159/000369585 · Cited by 79
Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy
Narayanan, S., Srinivas, S., & Feldman, D. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.254 · Cited by 90
Immunosuppressive drugs modes of action
Meneghini, M., Bestard, O., & Grinyo, J. M. (2021) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2021.101757 · Cited by 99
Radiation Therapy and Immunotherapy: What is the Optimal Timing or Sequencing?
Aliru, M. L., Schoenhals, J. E., Venkatesulu, B. P., Anderson, C., Barsoumian, H. B., Younes, A. I. A., Mahadevan, L. S. K., Soeung, M., Aziz, K. E., Welsh, J. W., et al. (2018) · Immunotherapy · doi:10.2217/imt-2017-0082 · Cited by 88
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
Perico, N., Cortinovis, M., Suter, F., & Remuzzi, G. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00433-9 · Cited by 93
Djordjevic, J., Djordjevic, A. D., Adzic, M., Niciforovic, A. P., & Radojčić, M. (2010) · Physiological Research · doi:10.33549/physiolres.931862 · Cited by 95
Burm, S. M., Zuiderwijk-Sick, E. A., ‘t Jong, A. E. J., van der Putten, C., Veth, J., Kondova, I., & Bajramovic, J. J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2510-14.2015 · Cited by 82
“Transcription factor analysis (Champion ChiP Transcription Factor Search Portal, Qiagen; Lee et al., 1987; Cogswell et al., 1994; De Bosscher et al., 2003) revealed that the promoter regions of these cytokines share binding sites for the transcription factors NF B, AP-1, C/EBP (CCAAT/enhancer…”
Clinical Implications of Inflammation in Acute Myeloid Leukemia
Récher, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.623952 · Cited by 96
Sheng, M., Chen, Y., Li, H., Zhang, Y., & Zhang, Z. (2023) · Burns & Trauma · doi:10.1093/burnst/tkad009 · Cited by 82
Kim, E. M., Lee, J. R., Koo, B.-N., Im, Y. J., Oh, H. J., & Lee, J. H. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aet484 · Cited by 81
NFκB and AP-1 Drive Human Myometrial IL8 Expression
Khanjani, S., Terzidou, V., Johnson, M. R., & Bennett, P. R. (2012) · Mediators of Inflammation · doi:10.1155/2012/504952 · Cited by 81
Reber, L. L., Daubeuf, F., Plantinga, M., Cauwer, L. D., Gerlo, S., Waelput, W., Calenbergh, S. V., Tavernier, J. H., Haegeman, G., Lambrecht, B. N., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1004227 · Cited by 88
Self-citationExtra-adrenal glucocorticoid synthesis: immune regulation and aspects on local organ homeostasis
Talabér, G., Jondal, M., & Okret, S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.05.007 · Cited by 80
Neddylation plays an important role in the regulation of murine and human dendritic cell function
Mathewson, N. D., Toubai, T., Kapeles, S. R., Sun, Y., Oravecz-Wilson, K. I., Tamaki, H., Wang, Y., Hou, G., Sun, Y., & Reddy, P. R. (2013) · Blood · doi:10.1182/blood-2013-02-486373 · Cited by 83
Weikum, E. R., de Vera, I. M. S., Nwachukwu, J. C., Hudson, W. H., Nettles, K. W., Kojetin, D. J., & Ortlund, E. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx509 · Cited by 86
Yang, C., Ko, S., Cho, B.-G., Shin, D. M., Yuk, J., Li, S., Kim, J., Evans, R. M., Jung, J., Song, D., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00181.x · Cited by 81
De Bosscher, K., Beck, I. M., Dejager, L., Bougarne, N., Gaigneaux, A., Chateauvieux, S., Ratman, D., Bracke, M., Tavernier, J., Vanden Berghe, W., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1367-4 · Cited by 75
Self-citationvan Weert, L. T. C. M., Buurstede, J. C., Mahfouz, A. E., Braakhuis, P. S. M., Polman, J. A. E., Sips, H. C. M., Roozendaal, B., Balog, J., de Kloet, E. R., Datson, N. A., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1422 · Cited by 84
Marine Diterpenoids as Potential Anti‐Inflammatory Agents
González, Y., Torres‐Mendoza, D., Jones, G. E., & Fernández, P. L. (2015) · Mediators of Inflammation · doi:10.1155/2015/263543 · Cited by 80
“Terpenoids can be classified into hemi, mono, sesqui, di, sester, or tri based”
BackgroundPatil, R. H., Kumar, M. N., Kumar, K. M. K., Nagesh, R., Kavya, K., Babu, R. L., Ramesh, G. T., & Sharma, S. C. (2017) · Gene · doi:10.1016/j.gene.2017.12.024 · Cited by 81
Sionov, R. V., Spokoini, R., Kfir‐Erenfeld, S., Cohen, O., & Yefenof, E. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00406-5 · Cited by 86
“As AP‐1 andNF B control several survival pathways, the interaction of GR with these factors are believed to play a major role in GC‐induced apoptosis (De Bosscher et al., 2003; Herrlich, 2001).”
BackgroundA Comprehensive Molecular Interaction Map for Rheumatoid Arthritis
Wu, G., Zhu, L., Dent, J. E., & Nardini, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010137 · Cited by 80
“Glucocorticoiks are an example of commonly used therapeutics that can modulate the NF-kB pathway through several mechanisms mentioned in [106].”
BackgroundVitamin D Enhances Glucocorticoid Action in Human Monocytes
Zhang, Y., Leung, D. Y. M., & Goleva, E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.427054 · Cited by 77
Tas, S., Vervoordeldonk, M., Hajji, N., May, M., Ghosh, S., & Tak, P. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1958 · Cited by 87
“Of these drugs, glucocorticoids like dexamethasone and prednisolone (although non-specific) are considered the most powerful NF-κB inhibitors [34,35].”
Kang, S., Tsai, L. T., Zhou, Y., Evertts, A., Xu, S., Griffin, M. J., Issner, R., Whitton, H. J., Garcia, B. A., Epstein, C. B., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3080 · Cited by 77
In Vitro Inhibition of the Transcription Factor NF‐κB and Cyclooxygenase by Bamboo Extracts
Hoyweghen, L. V., Bosscher, K. D., Haegeman, G., Deforce, D. L. D., & Heyerick, A. (2013) · Phytotherapy Research · doi:10.1002/ptr.4978 · Cited by 77
“A range of immunoregulatory genes coding for cytokines, cytokine receptors, chemotactic proteins, or adhesion molecules contain NF-kB and/or AP-1 sites in their promoters or regulatory regions (De Bosscher et al., 2003).”
BackgroundSelf-citationIL-1β induction ofMUC5ACgene expression is mediated by CREB and NF-κB and repressed by dexamethasone
Chen, Y., Garvin, L. M., Nickola, T. J., Watson, A. M., Colberg‐Poley, A. M., & Rose, M. C. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00347.2013 · Cited by 77
Li, A. C., & Palinski, W. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141247 · Cited by 86
Sergerie, Y., Boivin, G., Gosselin, D., & Rivest, S. (2007) · The Journal of Infectious Diseases · doi:10.1086/511987 · Cited by 89
Yang, N., Zhang, W., & Shi, X. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21562 · Cited by 73
“GCs are known to counteract the key inflammatory signaling mediators, NF-kB and AP-1, through a mechanism involving the GC receptors (GRs) [Auphan et al., 1995; De Bosscher et al., 2003].”
BackgroundRobertson, S., Allie-Reid, F., Berghe, W. V., Visser, K., Binder, A., Africander, D., Vismer, M., De Bosscher, K., Hapgood, J., Haegeman, G., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087866 · Cited by 75
Self-citationComparative enzymology of 11β-hydroxysteroid dehydrogenase type 1 from six species
Arampatzis, S., Kadereit, B., Schuster, D., Balazs, Z., Schweizer, R. A. S., Frey, F. J., Langer, T., & Odermatt, A. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01736 · Cited by 76
Regulation of Lung Epithelial Sodium Channels by Cytokines and Chemokines
Wynne, B. M., Zou, L., Linck, V., Hoover, R. S., Ma, H., & Eaton, D. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00766 · Cited by 75
TheCables1Gene in Glucocorticoid Regulation of Pituitary Corticotrope Growth and Cushing Disease
Roussel-Gervais, A., Couture, C., Langlais, D., Takayasu, S., Balsalobre, A., Rueda, B. R., Zukerberg, L. R., Figarella‐Branger, D., Brue, T. C., & Drouin, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3324 · Cited by 74
Yang, F., Ma, Q., Liu, Z., Li, W., Tan, Y., Jin, C., Ma, W., Hu, Y., Shen, J., Ohgi, K. A., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.03.019 · Cited by 76
“…trans-repression through inhibiting AP1/NF-kB activity, GR directly binding to the negative DNAbinding sites, andGR recruitment of the corepressor GRIP1 (Chinenov et al., 2012; De Bosscher et al., 2003; Glass and Saijo, 2010; Gupte et al., 2013; Rogatsky et al., 2002, 2003; Surjit et al., 2011).”
BackgroundChromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα
Ratman, D., Mylka, V., Bougarne, N., Pawlak, M., Caron, S., Hennuyer, N., Paumelle, R., De Cauwer, L., Thommis, J., Rider, M. H., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw742 · Cited by 72
“Ubiquitously expressed GR is predominantly studied for its potent anti-inflammatory action mechanisms (10).”
BackgroundLesovaya, E. A., Yemelyanov, A. Y., Swart, A. C., Swart, P., Haegeman, G., & Budunova, I. V. (2015) · Oncotarget · doi:10.18632/oncotarget.5078 · Cited by 77
“The GR belongs to a superfamily of nuclear hormone receptors and shares a characteristic threedomain structure: a variable N-terminal region with transactivation domain responsible for gene activation, a conserved central DNA-binding domain with dimerization and nuclear localization sequences, and a conserved C-termin…”
InfluentialSelf-citationGlucocorticoid-Induced Attenuation of the Inflammatory Response in Zebrafish
Chatzopoulou, A., Heijmans, J. P. M., Burgerhout, E., Oskam, N., Spaink, H. P., Meijer, A. H., & Schaaf, M. J. M. (2016) · Endocrinology · doi:10.1210/en.2015-2050 · Cited by 75
Maatouk, L., Yi, C., Carrillo-de Sauvage, M.-A., Compagnion, A.-C., Hunot, S., Ezan, P., Hirsch, E. C., Koulakoff, A., Pfrieger, F. W., Tronche, F., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0150-3 · Cited by 70
Dendoncker, K., Timmermans, S., Vandewalle, J., Eggermont, M., Lempiäinen, J. K., Paakinaho, V., Hamme, E. V., Dewaele, S., Vandevyver, S., Ballegeer, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821565116 · Cited by 78
Immune modulatory therapies for spinal cord injury – Past, present and future
Plemel, J. R., Yong, V. W., & Stirling, D. P. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.025 · Cited by 78
Crosstalk between TNF and glucocorticoid receptor signaling pathways
Bogaert, T. V., Bosscher, K. D., & Libert, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.04.003 · Cited by 80
“The mechanism by which GR represses the activity of these transcription factors has been extensively reviewed [41,54,55] and”
BackgroundRauch, A., Gossye, V., Bracke, D., Gevaert, E., Jacques, P., Van Beneden, K., Vandooren, B., Rauner, M., Hofbauer, L. C., Haegeman, G., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-173393 · Cited by 69
Self-citationDvořák, Z., Vrzal, R., Maurel, P., & Ulrichová, J. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.10.105 · Cited by 79
So, H., Lam, T. T., Meng, H., Lam, S. H. M., & Tam, L. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224185 · Cited by 78
Bosscher, K. D., Beck, I. M. E., & Haegeman, G. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.06.010 · Cited by 112
“The above described transrepression mechanism forms the basis by which activated GR can interfere with the activity of proinflammatory transcription factors, among which NF-jB- and AP1-targeting mechanisms are best described (Beck et al., 2009; De Bosscher et al., 2003).”
BackgroundSelf-citationPiette, C., Deprez, M., Roger, T., Noël, A., Foidart, J., & Munaut, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014589 · Cited by 86
Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism
Zhou, J., Liu, D., Liu, C., Kang, Z. ‐., Shen, X., Chen, Y., Xu, T., & Jiang, C. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01725.x · Cited by 70
Structure and Function of the Glucocorticoid Receptor Ligand Binding Domain
Bledsoe, R. K., Stewart, E. L., & Pearce, K. H. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)68002-2 · Cited by 82
Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases
Iudicibus, S. D., Stocco, G., Martelossi, S., Londero, M., Ebner, E., Pontillo, A., Lionetti, P., Barabino, A. V., Bartoli, F., Ventura, A., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181e8ae93 · Cited by 74
Anti-inflammatory activity of ginsenosides in LPS-stimulated RAW 264.7 cells
Ahn, S., Siddiqi, M. H., Noh, H.-Y., Kim, Y.-J., Kim, Y.-J., Jin, C.-G., & Yang, D. (2015) · 中国科学通报:英文版 · doi:10.1007/s11434-015-0773-4 · Cited by 72
Bellan, M., Andréoli, L., Mele, C., Sainaghi, P. P., Rigamonti, C., Piantoni, S., Benedittis, C. D., Aimaretti, G., Pirisi, M., & Marzullo, P. (2020) · Nutrients · doi:10.3390/nu12030789 · Cited by 80
Rollins, D. A., Coppo, M., & Rogatsky, I. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1005 · Cited by 74
Baida, G. E., Bhalla, P., Игоревич, К. К., Lesovaya, E. A., Геннадиевна, Я. М., Yuen, K., Guo, S., Lavker, R. M., Readhead, B., Dudley, J. T., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404601 · Cited by 76
“…(TR) by glucocorticoids is mediated by diverse mechanisms including interaction between GR and other transcription factors, such as major pro-inflammatory factors NF-jB and AP-1 (De Bosscher et al, 2003; Necela & Cidlowski, 2004; Schäcke et al, 2006; Chebotaev et al, 2007a; Ratman et al, 2013).”
BackgroundThe glucocorticoid receptor signalling in breast cancer
Moutsatsou, P., & Papavassiliou, A. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00177.x · Cited by 65
Activation of the Glucocorticoid Receptor in Acute Inflammation: the SEDIGRAM Concept
Bosscher, K. D., Beck, I. M. E., Ratman, D., Berghe, W. V., & Libert, C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.09.002 · Cited by 71
“The latter mechanism, first discovered in 1990 [11–13], explained that GCs act as potent immunosuppressants because the targeted transcription factors typically included the pro-inflammatory transcription factors nuclear factor kappa B (NF-kB) and activator protein 1 (AP-1) [14–16].”
It takes two to tango: Dimerisation of glucocorticoid receptor and its anti-inflammatory functions
Nixon, M., Andrew, R., & Chapman, K. E. (2012) · Steroids · doi:10.1016/j.steroids.2012.09.013 · Cited by 74
Implicating the Role of GILZ in Glucocorticoid Modulation of T-Cell Activation
Cannarile, L., Delfino, D. V., Adorisio, S., Riccardi, C., & Ayroldi, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01823 · Cited by 60
Frank, F., Liu, X., & Ortlund, E. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024685118 · Cited by 68
Glucocorticoids Suppress Tumor Lymphangiogenesis of Prostate Cancer Cells
Yano, A., Fujii, Y., Iwai, A., Kawakami, S., Kageyama, Y., & Kihara, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0749 · Cited by 66
Tumor Necrosis Factor Inhibits Glucocorticoid Receptor Function in Mice
Van Bogaert, T., Vandevyver, S., Dejager, L., Van Hauwermeiren, F., Pinheiro, I., Petta, I., Engblom, D., Kleyman, A., Schütz, G., Tuckermann, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212365 · Cited by 64
Lu, Y., Zhang, Z., Xiong, X., Wang, X., Li, J., Shi, G., Yang, J., Zhang, X., Zhang, H., Hong, J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.029 · Cited by 67
Charmandari, E., Kino, T., Ichijo, T., Zachman, K., Alatsatianos, A., & Chrousos, G. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1893 · Cited by 63
Role of glucocorticoids in dopamine-related neuropsychiatric disorders
Craenenbroeck, K. V., Bosscher, K. D., Berghe, W. V., Vanhoenacker, P., & Haegeman, G. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.007 · Cited by 64
Self-citationStructural insights into p300 regulation and acetylation-dependent genome organisation
Ibrahim, Z., Wang, T., Destaing, O., Salvi, N., Hoghoughi, N., Chabert, C., Rusu, A., Gao, J., Feletto, L., Reynoird, N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35375-2 · Cited by 64
Zöller, N. N., Kippenberger, S., Thaçi, D., Mewes, K. R., Spiegel, M., Sättler, A., Schultz, M., Bereiter‐Hahn, J., Kaufmann, R., & Bernd, A. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.11.022 · Cited by 64
Neuroendocrine Immunoregulation in Multiple Sclerosis
Deckx, N., Lee, W.-P., Berneman, Z. N., & Cools, N. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/705232 · Cited by 68
Chrysoeriol potently inhibits the induction of nitric oxide synthase by blocking AP-1 activation
Choi, D.-Y., Lee, J. Y., Kim, M.-R., Woo, E., Kim, Y. G., & Kang, K. W. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-005-9028-8 · Cited by 65
Mattaliano, M. D., Huard, C., Cao, W., Hill, A. A. V., Zhong, W., Martinez, R. V. P., Harnish, D. C., Paulsen, J. E., & Shih, H. H. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00513.2008 · Cited by 64
Gong, L., Wei, F., Gonzalez, F. J., & Li, G. (2023) · Hepatology · doi:10.1097/hep.0000000000000182 · Cited by 71
Glucocorticoid receptor and nuclear factor kappa-b affect three-dimensional chromatin organization
Kuznetsova, T., Wang, S.-Y., Rao, N. A., Mandoli, A., Martens, J. H. A., Rother, N., Aartse, A., Groh, L., Janssen-Megens, E. M., Li, G., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0832-9 · Cited by 57
“Ligand-activated GR binds to several thousand genomic loci [5, 7, 8, 41], of which more than 90 % (7679/8303) were located distally (>5 kb) from transcription start sites in HeLa cells (Additional file 1: Figure S1A).”
Long-term consequences of prenatal stress and neurotoxicants exposure on neurodevelopment
Antonelli, M. C., Pallarés, M. E., Ceccatelli, S., & Spulber, S. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.005 · Cited by 60
“For example, AP-1 and CREB, specific motifs for transcription factors have been described as target for negatively transcriptional regulation by GR in cytokines promoters (De Bosscher et al., 2003).”
Loo, G., Sze, M., Bougarne, N., Praet, J., Guire, C. M., Ullrich, A., Haegeman, G., Prinz, M., Beyaert, R., & Bosscher, K. D. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0236 · Cited by 70
“nisms may account for the inhibitory activity of GCs on NF- B-driven gene expression, ranging from a loss of NF- B from the DNA but maintaining a nuclear phenotype or a loss of NF- B from the DNA coupled to the translocation of NF- B out of the nucleus, to an interference mechanism between the activated GR and NF- B w…”
BackgroundSelf-citationIanaro, A., Tersigni, M., & D’Acquisto, F. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557510909030306 · Cited by 64
“Negative regulation of inflammatory responses is thought to result, at least in part, from the ability of GR to interfere with the activities of other signaldependent transcription factors, including NF- B and AP-1 family members, via transrepression [92].”
BackgroundCorticosteroids in severe pneumonia: Table 1—
Sibila, O., Agustí, C., & Torres, A. (2008) · European Respiratory Journal · doi:10.1183/09031936.00154107 · Cited by 62
Huijbregts, R. P. H., Michel, K. G., & Hel, Z. (2014) · Contraception · doi:10.1016/j.contraception.2014.02.006 · Cited by 70
Yemelyanov, A. Y., Czwornog, J. L., Gera, L., Joshi, S. S., Chatterton, R. T., & Budunova, I. V. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6104 · Cited by 67
“Indirect, DNA-independent mechanisms of GR gene regulation seem to be critical for the antiinflammatory effects of glucocorticoids ( 13 ).”
BackgroundInfluentialNewton, R., & Giembycz, M. A. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13628 · Cited by 69
“However, rather than agonist-bound GR causing repression of these genes, as is routinely established for other NF-κBdependent inflammatory genes (De Bosscher et al., 2003), there is a robust, positive, transcriptional cooperativity between NF-κB and GR that leads to enhanced TNFAIP3 and IRAK3…”
BackgroundGlucocorticoid‐mediated mechanisms of hippocampal damage: Contribution of subgranular neurogenesis
Podgorny, O. V., & Gulyaeva, N. V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15265 · Cited by 65
“…with some transcription factors (e.g., AP-1, NF-κB, and STAT3), modulating their binding to the respective regulatory sequences in the DNA and thus repressing or enhancing gene expression (De Bosscher et al., 2003; McKay & Cidlowski, 1999; Ramamoorthy & Cidlowski, 2016; Timmermans et al., 2019).”
BackgroundLim, W., Park, C., Shim, M. K., Lee, Y. H., Lee, Y., & Lee, Y. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12491 · Cited by 64
“Glucocorticoids play a key role in the suppression of inflammation by inhibiting the transcription of the cytokines through binding to the GR and the activated GR interacts with transcription factors, such as AP-1, NF-κB and CCAAT/enhancer-binding protein-β (De Bosscher et al., 2003).”
BackgroundHu, X., Du, S., Tunca, C., Braden, T., Long, K. R., Lee, J., Webb, E. G., Dietz, J. D., Hummert, S., Rouw, S., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1447 · Cited by 63
Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness.
Kale, S. S., & Yende, S. P. (2011) · Europe PMC (PubMed Central) · Cited by 80
Leigh, R., Mostafa, M., King, E. M., Rider, C. F., Shah, S., Dumonceaux, C., Traves, S. L., McWhae, A., Kolisnik, T., Kooi, C., et al. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.243 · Cited by 64
“One mechanism for this may involve direct GR interaction with, and reduction in the activity of transcription factors, such as NF-jB or AP-1 that drive inflammatory gene expression (De Bosscher et al. 2003).”
Horowitz, M. A., Cattaneo, A., Cattane, N., Lopizzo, N., Tojo, L. M., Bakunina, N., Musaelyan, K., Borsini, A., Zunszain, P. A., & Pariante, C. M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.012 · Cited by 62
Papakostas, S., Vasemägi, A., Vähä, J., Himberg, M., Peil, L., & Primmer, C. R. (2012) · Molecular Ecology · doi:10.1111/j.1365-294x.2012.05553.x · Cited by 68
“Glucocorticoid receptor is a transcription factor that regulates several genes in a positive or negative way (McKay & Cidlowski 1999; De Bosscher et al. 2003).”
BackgroundOKADA, Y., NAWATA, M., NAKAYAMADA, S., SAITO, K., & TANAKA, Y. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080168 · Cited by 60
“With regard to the higher rate of bone loss in the alfacalcidol group in our study, we consider that the rate of bone loss observed in the alfacalcidol group in the 6 months of this study depends upon the high dose of GC for the following reasons: (1) we used a higher dose of GC (1 mg/kg/day) for the treatment of syst…”
BackgroundResultGlucocorticoid receptor signaling and prostate cancer
Kassi, E. N., & Moutsatsou, P. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.020 · Cited by 69
“effects [29–31].”
Anthrax lethal factor represses glucocorticoid and progesterone receptor activity
Webster, J. I., Tonelli, L. H., Moayeri, M., Simons, S. S., Leppla, S. H., & STERNBERG, E. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1036973100 · Cited by 64
Gossye, V., Elewaut, D. S., Bougarne, N., Bracke, D., Calenbergh, S. V., Haegeman, G., & Bosscher, K. D. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24963 · Cited by 59
Self-citationKuryłowicz, A., & Nauman, J. A. (2008) · Acta Biochimica Polonica · doi:10.18388/abp.2008_3023 · Cited by 65
Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis
Czaja, A. J., & Montaño‐Loza, A. J. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5351-6 · Cited by 63
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids
Ayyar, V. S., & Jusko, W. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018101 · Cited by 62
“The genomic actions of CS, often divided into categories of transactivation and transrepression, have been extensively reviewed (De Bosscher et al., 2003).”
BackgroundRegulation of bim in glucocorticoid‐mediated osteoblast apoptosis
Espina, B., Liang, M., Russell, R. G. G., & Hulley, P. A. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21335 · Cited by 59
Zaveri, N. T., & Murphy, B. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00063-8 · Cited by 64
Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients
Spiliotaki, M., Salpeas, V., Malitas, P., Alevizos, V., & Moutsatsou, P. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.02.006 · Cited by 58
Kadiyala, V., Sasse, S. K., Altonsy, M. O., Berman, R., Chu, H. W., Phang, T. L., & Gerber, A. N. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721217 · Cited by 56
Intestinal hormones and growth factors: Effects on the small intestine
Drozdowski, L. A., & Thomson, A. B. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.385 · Cited by 63
Metadata
- Authors
- De Bosscher, K., Vanden Berghe, W., & Haegeman, G.
- Affiliations
- Department of Molecular Biology, Ghent University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium
- Ghent University (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 488-522
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2053125671
- Cited by
- 898
- References
- 808
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 13 · 2023: 24 · 2022: 22 · 2021: 41 · 2020: 30 · 2019: 20 · 2018: 26 · 2017: 46 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 41 · 2012: 48
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glucocorticoid receptor, NF-κB, activator protein-1, gene repression, anti-inflammatory mechanism, inflammation, signal transduction, glucocorticoids, transcriptional regulation, rheumatoid arthritis, asthma, allograft rejection, allergic skin diseases
- MeSH terms
- Gene Expression Regulation, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid, Signal Transduction, NF-kappa B, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.